Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Syracuse, NY MSA — September 2026
Syracuse life sci pay splits sharply by function, not by market.
Validation Engineer pay climbed to $105,849 locally while Lab Technician pay fell to $40,114, even as metro unemployment held flat at 4.1% and job growth nearly stalled.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Syracuse metro unemployment: 4.1% — Unchanged since July 2026; Onondaga County same
- Metro job growth pace 2026: 25 jobs/month avg — vs 350/month average in 2025
- NY pharma/biotech employment: 23,643 jobs — Record high, Aug 2026 (NYS)
- BioSpace NY job postings: -39% YoY — Signals selective hiring despite record headcount
Key takeaways
Validation Engineer pay is detaching from the local labor market.
Advertised pay rose significantly both locally ($105,849) and nationally ($108,377) even as Syracuse's broader job growth flattened to near zero in 2026. Compensation here reflects national CMC and manufacturing talent scarcity, not metro-level demand conditions — benchmarking this role against local wage trends alone risks underpricing it.
Lab Technician pay erosion may reflect a softening entry-level pipeline, not scarcity.
Metro advertised pay for Lab Technicians fell significantly ($40,114) while national postings also declined moderately, a pattern consistent with Syracuse's near-stagnant job growth and reduced urgency in filling entry-level roles. Leaders relying on this role as an internal talent pipeline should watch whether lower advertised pay is slowing qualified applicant flow.
Clinical Research Associate demand is outpacing the metro's flat hiring backdrop.
CRA advertised pay rose significantly both locally ($72,500) and nationally ($90,956), a notable divergence from Onondaga County's otherwise muted job growth. This suggests clinical operations roles are drawing premium pay locally even in a metro where overall employer hiring urgency has cooled.
New York's record pharma-biotech headcount coexists with a 39% drop in postings.
Statewide pharma and biotech jobs hit a record 23,643 even as BioSpace postings fell 39% year-over-year, indicating employers are retaining headcount while hiring more selectively. For Syracuse-based operations, this points toward internal mobility and retention programs mattering more than external recruiting volume this quarter.
Median advertised pay by role — Syracuse, NY MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $71,186 | $78,177 | $106,188 | Moderate decline | $131,354 |
| Clinical Research Associate | $64,177 | $72,500 | $78,226 | Significant increase | $90,956 |
| Lab Technician | $39,520 | $40,114 | $46,725 | Significant decline | $47,402 |
| Regulatory Affairs Specialist | $62,518 | $80,704 | $87,100 | Stable | $104,000 |
| Clinical Data Manager * | $103,367 | $123,978 | $136,385 | Significant decline | $123,031 |
| Biostatistician * | $109,100 | $140,725 | $175,000 | Moderate increase | $133,322 |
| Validation Engineer * | $95,728 | $105,849 | $119,600 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Syracuse metro unemployment held at 4.1% through August, with Onondaga County employment up 2.0% year-over-year even as the region's overall job growth has nearly stalled, averaging just 25 net new jobs monthly in 2026 versus 350 in 2025. Recent WARN filings from Piedmont Airlines and FedEx signal localized contraction in logistics and aviation rather than life sciences, leaving the metro's thin specialized scientific and regulatory labor pool largely undisturbed by broader churn.
What it means
Flat metro-wide job growth combined with a Validation Engineer market showing significant advertised pay gains ($105,849 locally, tracking the national $108,377 median) suggests Syracuse employers are bidding up a narrow set of manufacturing-adjacent, credential-driven roles even as overall hiring activity cools. Upstate Medical University's and Syracuse University's dominance as the metro's largest employers means private biotech and device employers compete directly against academic medical systems for quality, regulatory, and clinical talent rather than against each other. Consider reviewing validation, quality, and CMC-adjacent compensation bands against national trajectories rather than local wage trends, since these functions appear to be pricing off a national scarcity signal rather than Syracuse's soft overall labor market.
Looking ahead
Worth watching: Amazon's proposed Morgan Road warehouse expansion in Clay could tighten the metro's broader logistics and skilled-trades labor pool, indirectly pressuring wages for manufacturing and quality technicians who compete for similar shift-based talent pools.
Emerging pressure point: New York's regulatory affairs and advanced-therapy talent remains scarce statewide even as national VP Regulatory Affairs compensation reaches $320K-$580K; Syracuse employers recruiting into these functions should expect to compete against Boston- and NYC-area offers for the same thin candidate pool.
Early indicator: Statewide WARN filings show healthcare and manufacturing as the top two affected industries by notice count; watch whether any Syracuse-area manufacturing displacement feeds specialized technicians into the regional CDMO or device talent pool over the next two months.
Potential inflection point: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions while execution-critical roles stay open; if this pattern extends to upstate New York operations, expect continued premium pay for validation, quality, and CMC roles even amid headline job cuts elsewhere.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.